Association of a miR-502-Binding Site Single Nucleotide Polymorphism in the 3'-Untranslated Region of SET8 and the TP53 Codon 72 Polymorphism with Cervical Cancer in the Chinese Population

This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either independently or jointly, might be associated with increased risk for cervical cancer. We genotyped SET8 and TP53 codon 72 polymorphisms of periph...

Full description

Saved in:
Bibliographic Details
Published inAsian Pacific journal of cancer prevention : APJCP Vol. 15; no. 16; pp. 6505 - 6510
Main Authors Yang, Shao-Di, Cai, Yan-Lin, Jiang, Pei, Li, Wen, Tang, Jian-Xin
Format Journal Article
LanguageEnglish
Published Thailand 01.01.2014
Subjects
Online AccessGet full text
ISSN1513-7368
2476-762X
DOI10.7314/APJCP.2014.15.16.6505

Cover

Abstract This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either independently or jointly, might be associated with increased risk for cervical cancer. We genotyped SET8 and TP53 codon 72 polymorphisms of peripheral blood DNA from 114 cervical cancer patients and 200 controls using the polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) and direct DNA sequencing. The frequency of SET8 CC (odds ratios (OR) = 2.717, 95% CI=1.436-5.141) or TP53 GG (OR=2.168, 95% CI=1.149-4.089) genotype was associated with an increased risk of cervical cancer on comparison with the SET8 TT or TP53 CC genotypes, respectively. In additional, interaction between the SET8 and TP53 polymorphisms increased the risk of cervical cancer in a synergistic manner, with the OR being 9.913 (95% CI=2.028-48.459) for subjects carrying both SET8 CC and TP53 GG genotypes. These data suggest that there are significant associations between the miR-502-binding site SNP in the 3'-UTR of SET8 and the TP53 codon 72 polymorphism with cervical cancer in Chinese, and there is a gene-gene interaction.
AbstractList This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either independently or jointly, might be associated with increased risk for cervical cancer. We genotyped SET8 and TP53 codon 72 polymorphisms of peripheral blood DNA from 114 cervical cancer patients and 200 controls using the polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) and direct DNA sequencing. The frequency of SET8 CC (odds ratios (OR) = 2.717, 95% CI=1.436-5.141) or TP53 GG (OR=2.168, 95% CI=1.149-4.089) genotype was associated with an increased risk of cervical cancer on comparison with the SET8 TT or TP53 CC genotypes, respectively. In additional, interaction between the SET8 and TP53 polymorphisms increased the risk of cervical cancer in a synergistic manner, with the OR being 9.913 (95% CI=2.028-48.459) for subjects carrying both SET8 CC and TP53 GG genotypes. These data suggest that there are significant associations between the miR-502-binding site SNP in the 3'-UTR of SET8 and the TP53 codon 72 polymorphism with cervical cancer in Chinese, and there is a gene-gene interaction.
Author Cai, Yan-Lin
Yang, Shao-Di
Li, Wen
Tang, Jian-Xin
Jiang, Pei
Author_xml – sequence: 1
  givenname: Shao-Di
  surname: Yang
  fullname: Yang, Shao-Di
– sequence: 2
  givenname: Yan-Lin
  surname: Cai
  fullname: Cai, Yan-Lin
– sequence: 3
  givenname: Pei
  surname: Jiang
  fullname: Jiang, Pei
– sequence: 4
  givenname: Wen
  surname: Li
  fullname: Li, Wen
– sequence: 5
  givenname: Jian-Xin
  surname: Tang
  fullname: Tang, Jian-Xin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25169478$$D View this record in MEDLINE/PubMed
BookMark eNqFUctuFDEQtFAQ2QQ-AeQbpxn8tkecllEgQRGsko3EbeTxY9doxl6NvaD8Gx_H7CZBgguX7kNXVXdXnYGTmKID4DVGtaSYvVuuPrermiDMasxrLGrBEX8GFoRJUUlBvp2ABeaYVpIKdQrOcv6OEONK8hfglHAsGibVAvxa5pxM0CWkCJOHGo7hpuKIVB9CtCFu4G0obi5xMzj4ZW8Gl0qwDq7ScD-mabcNeYQhwrJ1kL6t7mKZdMyDLs7CG7d5lL29WCuooz3C1itOYZvsPJLkb6GfoWxh66YfwegBtjoaNz2pt9sQXT5s3u2H48EvwXOvh-xePfZzcPfxYt1eVtdfP121y-vKUC5K1SArGoN7yqQnwhukRSMd10pz4ZVhijXKW-MN9bo3kpFeKUKUtLqnwtGenoM3D7q7fT862-2mMOrpvnuycQbwB4CZUs6T838gGHWHuLpjXN0hrg7zDovuENfMe_8Pz4RyfG12MQz_Yf8GcJacng
CitedBy_id crossref_primary_10_1016_j_mrrev_2017_06_002
crossref_primary_10_1016_j_canlet_2016_04_008
crossref_primary_10_1111_cpr_12751
crossref_primary_10_1042_BSR20160480
crossref_primary_10_4236_jbm_2020_811004
crossref_primary_10_1007_s13277_015_4467_y
crossref_primary_10_7314_APJCP_2014_15_23_10387
crossref_primary_10_1042_BSR20180702
crossref_primary_10_1099_jmm_0_000563
crossref_primary_10_18632_oncotarget_9099
Cites_doi 10.1128/MCB.01768-08
10.1016/j.cancergen.2012.04.010
10.1158/1541-7786.MCR-09-0117
10.1375/twin.15.1.79
10.1158/1078-0432.CCR-09-0826
10.1002/ijc.27352
10.1016/j.molcel.2007.07.012
10.7314/APJCP.2012.13.12.6423
10.1158/0008-5472.CAN-09-3541
10.7314/APJCP.2012.13.10.4909
10.1038/30400
10.1016/j.cancergencyto.2009.11.011
10.1371/journal.pone.0077024
10.1111/j.1348-0421.2005.tb03745.x
10.1002/path.2637
10.1073/pnas.1009353108
10.7314/APJCP.2013.14.11.6961
10.1038/sj.clpt.6100087
10.1002/jcb.22570
10.1158/1078-0432.CCR-12-1983
10.1007/s12032-009-9297-6
10.1111/j.1744-313X.2007.00678.x
10.1371/journal.pone.0048834
10.1136/bmj.e614
10.1016/j.molcel.2010.09.015
10.3892/etm.2012.469
10.1083/jcb.200706150
10.1074/jbc.M710579200
10.1016/j.molcel.2010.09.014
10.1083/jcb.200706179
10.1089/dna.2012.1718
10.1016/j.ygyno.2005.06.007
10.1101/gad.177444.111
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.7314/APJCP.2014.15.16.6505
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2476-762X
EndPage 6510
ExternalDocumentID 25169478
10_7314_APJCP_2014_15_16_6505
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
.UV
23N
2WC
53G
5GY
9ZL
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
CITATION
E3Z
EBS
EJD
F5P
FRJ
GROUPED_DOAJ
GX1
JDI
OK1
OVT
RPM
TR2
W2D
WOW
CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-c356t-90d69c1b347f26fc0a697e5a8a56f8c48498fdcfc3fabc742b882287dab36e3b3
ISSN 1513-7368
IngestDate Fri Sep 17 21:48:51 EDT 2021
Thu Apr 24 23:02:53 EDT 2025
Tue Jul 01 04:31:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c356t-90d69c1b347f26fc0a697e5a8a56f8c48498fdcfc3fabc742b882287dab36e3b3
OpenAccessLink http://koreascience.or.kr:80/article/JAKO201429765166956.pdf
PMID 25169478
PageCount 6
ParticipantIDs pubmed_primary_25169478
crossref_primary_10_7314_APJCP_2014_15_16_6505
crossref_citationtrail_10_7314_APJCP_2014_15_16_6505
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Thailand
PublicationPlace_xml – name: Thailand
PublicationTitle Asian Pacific journal of cancer prevention : APJCP
PublicationTitleAlternate Asian Pac J Cancer Prev
PublicationYear 2014
References (POCPA9_2014_v15n16_6505_009) 2010; 27
(POCPA9_2014_v15n16_6505_014) 2012; 131
(POCPA9_2014_v15n16_6505_017) 2008; 283
(POCPA9_2014_v15n16_6505_003) 2012; 26
(POCPA9_2014_v15n16_6505_005) 2010; 40
(POCPA9_2014_v15n16_6505_007) 2010; 110
(POCPA9_2014_v15n16_6505_008) 2012; 3
(POCPA9_2014_v15n16_6505_021) 2011; 108
(POCPA9_2014_v15n16_6505_029) 2013; 32
(POCPA9_2014_v15n16_6505_035) 2013; 8
(POCPA9_2014_v15n16_6505_025) 2010; 18
(POCPA9_2014_v15n16_6505_015) 2012; 18
(POCPA9_2014_v15n16_6505_020) 2009; 7
(POCPA9_2014_v15n16_6505_016) 2010; 220
POCPA9_2014_v15n16_6505_028
(POCPA9_2014_v15n16_6505_002) 2012; 7
(POCPA9_2014_v15n16_6505_018) 2010; 197
(POCPA9_2014_v15n16_6505_010) 2007; 81
(POCPA9_2014_v15n16_6505_027) 2007; 27
(POCPA9_2014_v15n16_6505_034) 2012; 205
(POCPA9_2014_v15n16_6505_012) 2013; 33
(POCPA9_2014_v15n16_6505_026) 2005; 49
(POCPA9_2014_v15n16_6505_013) 2007; 34
(POCPA9_2014_v15n16_6505_019) 2007; 179
(POCPA9_2014_v15n16_6505_011) 2012; 344
(POCPA9_2014_v15n16_6505_032) 1998; 393
(POCPA9_2014_v15n16_6505_001) 2010; 40
(POCPA9_2014_v15n16_6505_024) 2009; 29
POCPA9_2014_v15n16_6505_030
(POCPA9_2014_v15n16_6505_023) 2010; 70
(POCPA9_2014_v15n16_6505_031) 2009; 15
(POCPA9_2014_v15n16_6505_033) 2007; 179
POCPA9_2014_v15n16_6505_036
(POCPA9_2014_v15n16_6505_004) 2005; 99
(POCPA9_2014_v15n16_6505_022) 2012; 15
(POCPA9_2014_v15n16_6505_006) 2006; 26
References_xml – volume: 33
  start-page: 2561
  year: 2013
  ident: POCPA9_2014_v15n16_6505_012
  publication-title: Anticancer Res
– volume: 29
  start-page: 2278
  year: 2009
  ident: POCPA9_2014_v15n16_6505_024
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01768-08
– volume: 205
  start-page: 373
  year: 2012
  ident: POCPA9_2014_v15n16_6505_034
  publication-title: Cancer Genet
  doi: 10.1016/j.cancergen.2012.04.010
– volume: 7
  start-page: 1645
  year: 2009
  ident: POCPA9_2014_v15n16_6505_020
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-09-0117
– volume: 15
  start-page: 79
  year: 2012
  ident: POCPA9_2014_v15n16_6505_022
  publication-title: Twin Res Hum Genet
  doi: 10.1375/twin.15.1.79
– volume: 15
  start-page: 6292
  year: 2009
  ident: POCPA9_2014_v15n16_6505_031
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-09-0826
– volume: 131
  start-page: 1318
  year: 2012
  ident: POCPA9_2014_v15n16_6505_014
  publication-title: Int J Cancer
  doi: 10.1002/ijc.27352
– volume: 27
  start-page: 636
  year: 2007
  ident: POCPA9_2014_v15n16_6505_027
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2007.07.012
– ident: POCPA9_2014_v15n16_6505_028
  doi: 10.7314/APJCP.2012.13.12.6423
– volume: 70
  start-page: 2789
  year: 2010
  ident: POCPA9_2014_v15n16_6505_023
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3541
– ident: POCPA9_2014_v15n16_6505_036
  doi: 10.7314/APJCP.2012.13.10.4909
– volume: 393
  start-page: 229
  year: 1998
  ident: POCPA9_2014_v15n16_6505_032
  publication-title: Nature
  doi: 10.1038/30400
– volume: 197
  start-page: 174
  year: 2010
  ident: POCPA9_2014_v15n16_6505_018
  publication-title: Cancer Genetics and Cytogenetics
  doi: 10.1016/j.cancergencyto.2009.11.011
– volume: 8
  start-page: e77024
  year: 2013
  ident: POCPA9_2014_v15n16_6505_035
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0077024
– volume: 49
  start-page: 417
  year: 2005
  ident: POCPA9_2014_v15n16_6505_026
  publication-title: Microbiol Immunol
  doi: 10.1111/j.1348-0421.2005.tb03745.x
– volume: 220
  start-page: 164
  year: 2010
  ident: POCPA9_2014_v15n16_6505_016
  publication-title: J Pathology
  doi: 10.1002/path.2637
– volume: 108
  start-page: 3116
  year: 2011
  ident: POCPA9_2014_v15n16_6505_021
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1009353108
– ident: POCPA9_2014_v15n16_6505_030
  doi: 10.7314/APJCP.2013.14.11.6961
– volume: 81
  start-page: 328
  year: 2007
  ident: POCPA9_2014_v15n16_6505_010
  publication-title: Clinical Pharmacology & Therapeutics
  doi: 10.1038/sj.clpt.6100087
– volume: 110
  start-page: 609
  year: 2010
  ident: POCPA9_2014_v15n16_6505_007
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.22570
– volume: 18
  start-page: 6407
  year: 2012
  ident: POCPA9_2014_v15n16_6505_015
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-1983
– volume: 27
  start-page: 861
  year: 2010
  ident: POCPA9_2014_v15n16_6505_009
  publication-title: Med Oncol
  doi: 10.1007/s12032-009-9297-6
– volume: 34
  start-page: 213
  year: 2007
  ident: POCPA9_2014_v15n16_6505_013
  publication-title: Int J Immunogenet
  doi: 10.1111/j.1744-313X.2007.00678.x
– volume: 7
  start-page: e48834
  year: 2012
  ident: POCPA9_2014_v15n16_6505_002
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048834
– volume: 344
  start-page: e614
  year: 2012
  ident: POCPA9_2014_v15n16_6505_011
  publication-title: BMJ
  doi: 10.1136/bmj.e614
– volume: 40
  start-page: 22
  year: 2010
  ident: POCPA9_2014_v15n16_6505_005
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2010.09.015
– volume: 3
  start-page: 689
  year: 2012
  ident: POCPA9_2014_v15n16_6505_008
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2012.469
– volume: 179
  start-page: 1337
  year: 2007
  ident: POCPA9_2014_v15n16_6505_019
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200706150
– volume: 283
  start-page: 19478
  year: 2008
  ident: POCPA9_2014_v15n16_6505_017
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M710579200
– volume: 40
  start-page: 9
  year: 2010
  ident: POCPA9_2014_v15n16_6505_001
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2010.09.014
– volume: 179
  start-page: 1413
  year: 2007
  ident: POCPA9_2014_v15n16_6505_033
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200706179
– volume: 32
  start-page: 19
  year: 2013
  ident: POCPA9_2014_v15n16_6505_029
  publication-title: DNA Cell Biol
  doi: 10.1089/dna.2012.1718
– volume: 18
  start-page: 453
  year: 2010
  ident: POCPA9_2014_v15n16_6505_025
  publication-title: Oncol Res
– volume: 26
  start-page: 3745
  year: 2006
  ident: POCPA9_2014_v15n16_6505_006
  publication-title: Anticancer Res
– volume: 99
  start-page: 176
  year: 2005
  ident: POCPA9_2014_v15n16_6505_004
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2005.06.007
– volume: 26
  start-page: 325
  year: 2012
  ident: POCPA9_2014_v15n16_6505_003
  publication-title: Genes & Dev
  doi: 10.1101/gad.177444.111
SSID ssj0045875
Score 2.0910993
Snippet This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either...
SourceID pubmed
crossref
SourceType Index Database
Enrichment Source
StartPage 6505
SubjectTerms 3' Untranslated Regions - genetics
Asian Continental Ancestry Group - genetics
Base Sequence
Binding Sites - genetics
China
Female
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Histone-Lysine N-Methyltransferase - genetics
Humans
MicroRNAs - genetics
Middle Aged
Polymorphism, Restriction Fragment Length
Polymorphism, Single Nucleotide
Sequence Analysis, DNA
Tumor Suppressor Protein p53 - genetics
Uterine Cervical Neoplasms - genetics
Title Association of a miR-502-Binding Site Single Nucleotide Polymorphism in the 3'-Untranslated Region of SET8 and the TP53 Codon 72 Polymorphism with Cervical Cancer in the Chinese Population
URI https://www.ncbi.nlm.nih.gov/pubmed/25169478
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAviO-NL_kBxANKiWM7Th5HGZqqtaq2VoynyE6cEWmk0-he-Nv4u3jmLnbStJqA8WJVif1Lk_vFvrvcnQl5HVrNIpWGQaE0D8D-KoJURjYIdSgLnQBFLGYjT6bx4UKMT-XpYPCrF7V0tTLD_Me1eSX_I1U4BnLFLNkbSLYDhQPwG-QLLUgY2n-Sce_ZujzHb9VxIGHy-VC5ZJUTUCihqc_O7bspVi5erqrCYtAbmPzwhHGHDB_oyN9EKligq7cGlqAeemzPPPDJwTzpQi3nM8lhGinglIo2oRqn7qiZfdAngYS6bPFxo277Ha_d7hjW14v3m1xOHyHYL2eRO5ALX2kKuYquzNl41CWmfWld3l_1MvhYrb-qNIEKcDY4qrpXYFz53jPb9TxqOn72SXHeBcJEzwXiZ23GA8Xd_jzdtC779O1P0qCUyt6CH0sXWLu9mCjOBBa1wDvCGEAxZHLI4uF6eL9499ai2oU6gpGFQFkDkyFMxmTG4gxhbpHbkQKdr3UFOA1CyKQpEN3dlss8Q5j31_6bDZ1qwzpqtKT5fXLPmzd033H1ARnY-iG5M_EBHI_Izx5l6bKkmm5RliJlqaMsXVOW9nlGq5oCpSh_u0FY6giLsEhYCoRtuiFhaUNYqqJNICQsbQlLHWFbdE9YuibsY7L4dDAfHQZ-A5Eg5zJeBWlYxGnODBeqjOIyD3WcKit1omVcJrlIRJqURV7mvNQmVyIyYG9GiSq04bHlhj8hO_WytruEpkZwWxbCMgMau2YGi1IZUzJYweK4FHtEtCLIcl9dHzd5Oc_-SIA9MuyGXbjyMn8b8NTJt-se4ZduoZJnN4V6Tu6uX6YXZGd1eWVfgoa9Mq8aOkI7nU1-A6Wdy5o
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+a+miR-502-Binding+Site+Single+Nucleotide+Polymorphism+in+the+3%27-Untranslated+Region+of+SET8+and+the+TP53+Codon+72+Polymorphism+with+Cervical+Cancer+in+the+Chinese+Population&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Yang%2C+Shao-Di&rft.au=Cai%2C+Yan-Lin&rft.au=Jiang%2C+Pei&rft.au=Li%2C+Wen&rft.date=2014-01-01&rft.issn=1513-7368&rft.volume=15&rft.issue=16&rft.spage=6505&rft.epage=6510&rft_id=info:doi/10.7314%2FAPJCP.2014.15.16.6505&rft.externalDBID=n%2Fa&rft.externalDocID=10_7314_APJCP_2014_15_16_6505
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1513-7368&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1513-7368&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1513-7368&client=summon